Large-scale testing (Phase 3)Study completedNCT04777201
What this trial is testing
Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
Who this might be right for
Neovascular Age-related Macular Degeneration
Hoffmann-La Roche 1,036